Premium Information is available for this item - Upgrade for $1 a day

6505-00-254-5305

Usp Warfarin Sodium Tablets

6505002545305 002545305 C0UMADIN 56-0012-9H

6505-00-254-5305 WARFARIN SODIUM TABLETS,USP 6505002545305 002545305

Managed by United States
NSN Created on 22 Jun 1973
Data Last Changed
November 2023
NATO Update Count
7
NATO Data Quality
6505-00-254-5305 WARFARIN SODIUM TABLETS,USP 6505002545305 002545305 1/1
NSN 6505-00-254-5305 (Generic Image) 1/1

6505-00-254-5305 Stock and Availability Marketplace 6505-00-254-5305

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-00-254-5305 RQST NE eBay
eBay Updated Every Day
6505-00-254-5305 RQST eBay
Amazon Updated Every Day
6505-00-254-5305 RQST NE Amazon

6505-00-254-5305 Related Documents Related Documents 6505-00-254-5305 5+ Documents (More...)

C0UMADIN 56-0012-9H Managed by United States NSN Created on 22 Jun 1973 Data Last Changed November 2023
/fsg-65/fsc-6505/us 6505-00-254-5305 Usp Warfarin Sodium Tablets 6505002545305 Usp Warfarin Sodium Tablets
Usp Warfarin Sodium Tablets 6505002545305 Warfarin Sodium Tablets 6505002545305 5305 Usp Warfarin
-65/fsc-6505/tr 6505-27-005-7724 Warfarin Sodium Tablets 6505270057724 Warfarin Sodium Tablets 6505002545305
Usp Warfarin Sodium Tablets 6505002545305 Warfarin Sodium Tablets 6505002545305 https/ https https
6505/tr 6505-27-005-7724 Warfarin Sodium Tablets https//www.nsnlookup.com Warfarin Sodium Tablets 6505002545305
6505002001589 Tablets 6505002001589 https https https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-254-5305
Usp Warfarin Sodium Tablets 6505002545305 fsg-65/fsc-6505/us 6505-00-254-5305 Usp Warfarin Sodium
Tablets 6505002545305 6505270057724 us 6505-00-200-1589 https Tablets 6505002545305 https//www.nsnlookup.com
Upgrade your Account Upgrade 6505-00-227-7704Usp Warfarin Sodium For Injection6505002277704 002277704 C0UMADIN
65/fsc-6505/us 6505-00-227-7704 Usp Warfarin Sodium For Injection 002277704 Tablets6505002545305 002545305
C0UMADIN https https 6505/us 6505 https ThinnerSpecial Features [FEAT]Box Of 24 Vials NATO Stock Numbers
6505007282617 https https Sodium Tablets 6505002001576 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-254-5305
Usp Warfarin Sodium Tablets 6505002545305 254-5305Usp Warfarin Sodium Tablets6505002545305 https
052-2856 6505-27-005-7724 6505-00-973-8502 6505-00-200-1589 6505-21-846-1990 6505-01-049-1815 6505-00-254-5305

6505-00-254-5305 Demil Restrictions 6505-00-254-5305

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-00-254-5305 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-00-254-5305 End Users End Users 6505-00-254-5305

NASA (G04V)
Effective Date:
1 Apr 1991

6505-00-254-5305 Manufacturers Approved Sources 6505-00-254-5305

6505-00-254-5305 Technical Data Datasheet 6505-00-254-5305

Characteristic
Specifications
Active Medicament Medicinal Strength [AKJA]
5.000 Milligrams Warfarin Sodium Active Ingredient
Administration [CSGS]
Oral
Primary Container Type [CQCT]
Bottle
Primary Container Content Quantity [CRLK]
1000.000 Tablets

6505-00-254-5305 Related Items NATO Stock Numbers Related to 6505-00-254-5305

6505-00-254-5305 Freight Data Freight Information 6505-00-254-5305

6505-00-254-5305 has freight characteristics managed by Tunisia.. 6505-00-254-5305 has a variance between NMFC and UFC when transported by rail and the description should be consulted.